Navigation Links
Generic Products Compete With GlaxoSmithKline

Stiff competition offered by generic drug makers may well eat into the profit figures of GlaxoSmithKline, according to company sources. The Cox-2 painkiller of the organization is also likely to suffer as a result of this.// The company is also embroiled in a tax related dispute with the Government in the US. The sales of the company for the year rose by13% at £21.6 billion, while its earnings were at £6.7 billion.

The sales of Advair, an asthma drug rose to £851 million during the 2005 last quarter, in spite of the US Food and Drug Administration (FDA) expressing strong reservations with regard to the drug. The sales figure for Avandia was at £289 million for the same quarter, while Avandamet crossed the £46 million figure.

The management chose to be cautious with regard to the 2006 earnings as a result of low priced generic competitors for the antidepressant Wellbutrin XL, hay fever medication Flonase, and Zofran. The per share earnings for 2006 is forecast at only 10% by the company. The results of the Cox-2 painkiller’s phase-III tests are also not very encouraging, according to the management of GlaxoSmithKline. Further development with regard to the drug however is being undertaken.

As many as another seven medicines are expected to be launched in 2006, which are inclusive of Entereg, Arranon, and Avandaryl. The regulators will be called upon to give their approval for seven more medicines also, which is inclusive of an anti H5N1 bird flu vaccine. The organization is also seeking to make some acquisitions during the course of the year. The consumer healthcare business of Pfizer is reported to be one among the targets of the compay.
'"/>




Page: 1

Related medicine news :

1. Generic drug costs remain shackled
2. FDA Approves Indian Generic Drug For AIDS Treatment
3. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
4. AIDS Generic Drugs Approved by FDA for Sale in US
5. HIV Mortality declining in India due to Generic Antiretroviral therapy drugs
6. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
7. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
8. Ranbaxy Expands By Acquiring A Generic Company In Belgium
9. First Generic Version of Lexapro permitted by US
10. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
11. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... 18, 2017 , ... Visually learn facts and tips on ... Certain Dri. , Excessive sweating and hyperhidrosis are common conditions that occur in ... explain the seven types of hyperhidrosis. This visual creates awareness about the condition ...
(Date:1/18/2017)... Cary, NC (PRWEB) , ... January 18, 2017 , ... ... spots remain on Team V, its official endurance training and fundraising team, to compete ... the V Foundation welcomes those inspired to finish the world’s oldest annual marathon to ...
(Date:1/18/2017)... ... 18, 2017 , ... Park Agencies Insurance & Financial Services, ... and business owners in the greater Kansas City area, is joining the Lakemary ... The Lakemary Center is a comprehensive educational resource center that provides area children ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. ... website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President ... the field of biosimilars through thought leader interaction in, live video and interactive ...
(Date:1/18/2017)... ... 2017 , ... Floundering on New Year’s resolutions? Need an excuse to get ... reset. The U.S. Apple Association agrees and recommends starting each day with apples, ... to heart disease. , The U.S. Apple Association – which represents apple growers and ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Research and Markets has announced the addition of the ... to their offering. ... The global CINV drugs market to grow at a CAGR ... Surgery Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. To calculate ...
(Date:1/18/2017)... annual growth ranging from 6% to 10%, South East Asia,s ... 22-24, 2017) serves the industry by fostering the regional discourse - Sign up ... Investment Forum ASEAN -- India strategic ... Enhanced business matchmaking program Roadshows ... ...
(Date:1/18/2017)... Jan. 18, 2017   Seno Medical Instruments, Inc. ... breast cancer through the development of an opto-acoustic (OA/US) ... Miller as SVP of Engineering. Mr. Miller previously ... FUJIFILM SonoSite, with headquarters in Bothell, Washington ... his 30-year career to the development of innovative medical ...
Breaking Medicine Technology: